<h1>Sakar Healthcare Limited Board Meeting Scheduled to Review Unaudited Financial Results for Quarter Ended June 30, 2026</h1>
Sakar Healthcare Limited has scheduled a Board of Directors meeting to review and approve the company's Unaudited Financial Results for the quarter ending on June 30, 2026.
The meeting is set for July 24, 2026. The agenda for the Board includes considering and approving the Unaudited Financial Results for the specified quarter, as well as addressing other pertinent matters.
In addition to reviewing the financial outcomes, the company provided an update regarding trading protocols. Per the Company's Code of Conduct for prevention of Insider Trading, the trading window for designated persons will remain closed until 48 hours after the declaration of Financial Results for the quarter ended on June 30, 2026.
SAKAR Stock Price Movement
Today, shares of Sakar Healthcare Limited rallied, closing higher by 3.00% to settle at ₹898.8. The stock traded within a tight range, moving between a low of ₹865.65 and a high of ₹906.6 before the close, with 72,908 shares recorded in trade.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.